Daily Newsletter

12 August 2024

Daily Newsletter

12 August 2024

Sealed Air posts 2.6% drop in net sales for Q2 FY24  

The company’s EPS rose by 3.1% to $0.67 over the quarter.

Jangoulun Singsit August 09 2024

Global packaging solutions provider Sealed Air (SEE) has reported generally accepted accounting principles (GAAP) net sales of $1.34bn in the second quarter (Q2) of financial year 2024 (FY24), marking a 2.6% decline from $1.38bn in Q2 FY23.  

The company's net earnings were $97.8m in Q2 FY24, up by 4.2% from $93.9m in Q2 FY23. 

Its earnings per diluted share (EPS) also rose to $0.67, a 3.1% increase from the prior year's quarter of $0.65.  

SEE’s non-GAAP adjusted earnings before interest, taxes, depreciation, and amortisation improved to $285m in Q2 FY24, or 21.2% of net sales, compared to $280m, or 20.3%, in Q2 FY23.  

This rise was primarily due to lower operating costs from the CTO2Grow programme and higher volumes, despite challenges in net price realisation. 

The company's income tax expense decreased to $38m, with an effective tax rate of 27.8%, down from a 32.5% rate in the prior year.  

SEE total debt stood at $4.6bn as of 30 June 2024, a slight decrease from $4.7bn at the end of 2023.  

SEE CEO Patrick Kivits said: "Our second-quarter results were ahead of our expectations, reflecting strong sequential demand within our Food business and accelerated benefits from our CTO2Grow programme. 

"I have joined Sealed Air at a pivotal time in its journey. I plan on accelerating the transformation that began eight months ago to restore business fundamentals and drive long-term sustainable growth. Our people are at the centre of this transformation and I want to express my appreciation for their commitment to Sealed Air and our customers. I am excited about the opportunities ahead of us." 

Looking ahead, Sealed Air anticipates full-year net sales to be between $5.2bn and $5.6bn, with adjusted EPS ranging from $2.65 to $3.05. 

In June this year, SEE announced the appointment of Kivits as its new chief executive officer, effective 1 July.  

Pharmaceutical Packaging Market Overview

GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.

Pharmaceutical Packaging Market Overview

GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.

Pharmaceutical Packaging Market Overview

GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.

Pharmaceutical Packaging Market Overview

GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.

Pharmaceutical Packaging Market Overview

GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close